(Q33491829)

English

In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

27 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

Shigeharu Oie

1

1 reference

Europe PubMed Central

27 July 2017

Yumi Fukui

2

1 reference

Europe PubMed Central

27 July 2017

Masaya Yamamoto

3

1 reference

Europe PubMed Central

27 July 2017

Yuki Masuda

4

1 reference

Europe PubMed Central

27 July 2017

Akira Kamiya

5

1 reference

Europe PubMed Central

27 July 2017

publication date

10 August 2009

1 reference

Europe PubMed Central

27 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

27 July 2017

9

1 reference

Europe PubMed Central

27 July 2017

123

1 reference

Europe PubMed Central

27 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2334-9-123

0 references

Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Metallo-beta-lactamases: the quiet before the storm?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

In vitro synergistic effects of double and triple combinations of beta-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Carbapenem-hydrolyzing beta-lactamases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

21 June 2018

Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

Extended high-level cross-resistance to antipseudomonal antibiotics amongst Pseudomonas aeruginosa isolates in a university hospital.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-123

21 January 2018

Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738676

31 October 2018

In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19664245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/19664245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19664245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19664245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro interactions of DX-8739, a new carbapenem, meropenem and imipenem with amikacin against multiresistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19664245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/19664245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://pubmed.ncbi.nlm.nih.gov/19664245

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-9-123

1 reference

Europe PubMed Central

27 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33491829&oldid=1794540068"